1. Home
  2. PLAY vs OCS Comparison

PLAY vs OCS Comparison

Compare PLAY & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAY
  • OCS
  • Stock Information
  • Founded
  • PLAY 1982
  • OCS 2003
  • Country
  • PLAY United States
  • OCS Switzerland
  • Employees
  • PLAY N/A
  • OCS N/A
  • Industry
  • PLAY Restaurants
  • OCS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAY Consumer Discretionary
  • OCS Health Care
  • Exchange
  • PLAY Nasdaq
  • OCS Nasdaq
  • Market Cap
  • PLAY 1.1B
  • OCS 1.0B
  • IPO Year
  • PLAY 1995
  • OCS N/A
  • Fundamental
  • Price
  • PLAY $34.03
  • OCS $19.00
  • Analyst Decision
  • PLAY Hold
  • OCS Strong Buy
  • Analyst Count
  • PLAY 8
  • OCS 3
  • Target Price
  • PLAY $31.83
  • OCS $35.33
  • AVG Volume (30 Days)
  • PLAY 1.6M
  • OCS 27.1K
  • Earning Date
  • PLAY 06-10-2025
  • OCS 08-26-2025
  • Dividend Yield
  • PLAY N/A
  • OCS N/A
  • EPS Growth
  • PLAY N/A
  • OCS N/A
  • EPS
  • PLAY 1.02
  • OCS N/A
  • Revenue
  • PLAY $2,112,300,000.00
  • OCS $847,333.00
  • Revenue This Year
  • PLAY $3.62
  • OCS $18.70
  • Revenue Next Year
  • PLAY $6.33
  • OCS $1,059.78
  • P/E Ratio
  • PLAY $34.01
  • OCS N/A
  • Revenue Growth
  • PLAY N/A
  • OCS N/A
  • 52 Week Low
  • PLAY $15.08
  • OCS $10.79
  • 52 Week High
  • PLAY $43.73
  • OCS $23.08
  • Technical
  • Relative Strength Index (RSI)
  • PLAY 73.82
  • OCS 46.89
  • Support Level
  • PLAY $29.55
  • OCS $18.87
  • Resistance Level
  • PLAY $32.02
  • OCS $19.75
  • Average True Range (ATR)
  • PLAY 1.61
  • OCS 0.43
  • MACD
  • PLAY 0.01
  • OCS -0.11
  • Stochastic Oscillator
  • PLAY 83.61
  • OCS 32.43

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: